tiprankstipranks
Trending News
More News >
IN8bio (INAB)
NASDAQ:INAB
US Market

IN8bio (INAB) Financial Statements

Compare
448 Followers

IN8bio Financial Overview

IN8bio's market cap is currently $10.24M. The company's EPS TTM is $-0.85; its P/E ratio is -0.35; IN8bio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -2.50M$ -1.10M$ 0.00$ 0.00
Operating Income$ -30.44M$ -30.34M$ -28.52M$ -14.65M$ -8.56M
EBITDA$ -26.94M$ -27.51M$ -27.42M$ -13.87M$ -8.47M
Net Income$ -30.44M$ -30.01M$ -28.52M$ -14.65M$ -8.56M
Balance Sheet
Cash & Short-Term Investments$ 11.12M$ 21.28M$ 18.18M$ 37.02M$ 17.99M
Total Assets$ 20.94M$ 33.71M$ 33.04M$ 42.22M$ 20.91M
Total Debt$ 5.03M$ 4.89M$ 5.87M$ 2.41M$ 174.00K
Net Debt$ -6.09M$ -16.39M$ -12.31M$ -34.61M$ -17.82M
Total Liabilities$ 6.47M$ 8.77M$ 10.31M$ 4.04M$ 2.59M
Stockholders' Equity$ 14.48M$ 24.94M$ 22.73M$ 38.18M$ 18.32M
Cash Flow
Free Cash Flow$ -24.25M$ -23.94M$ -27.83M$ -13.82M$ -7.13M
Operating Cash Flow$ -24.15M$ -23.34M$ -24.12M$ -13.51M$ -7.13M
Investing Cash Flow$ -187.00K$ -600.00K$ -3.71M$ -309.00K$ 0.00
Financing Cash Flow$ 14.18M$ 27.04M$ 8.99M$ 32.95M$ 24.52M
Currency in USD

IN8bio Earnings and Revenue History

IN8bio Debt to Assets

IN8bio Cash Flow

IN8bio Forecast EPS vs Actual EPS